ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (HKG:1541)
Hong Kong · Delayed Price · Currency is HKD 3.780
+0.220 (6.18%)
Jun 18, 2026, 11:58 AM HKT
-72.00% (1Y)
| Market Cap | 1.54B -61.9% |
| Revenue (ttm) | 171.70M +108.1% |
| Net Income | -243.24M |
| EPS | -0.59 |
| Shares Out | 431.51M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 959,800 |
| Open | 3.580 |
| Previous Close | 3.560 |
| Day's Range | 3.570 - 3.830 |
| 52-Week Range | 2.800 - 16.800 |
| Beta | 0.33 |
| Analysts | Strong Buy |
| Price Target | 23.17 (+512.96%) |
| Earnings Date | Aug 21, 2026 |